8 matches for your search in the start-up spotlight
rss
Founded in 2022, AlgenScribe SAS is actively crafting a genome editing framework tailored for Human Health encompassing therapeutics, bioproduction, research tools and diagnostics. AlgenScribe's objective is to unlock the complete potential of genome editing, focused on eliminating obstacles that ...
At Leopard Biosciences, we are democratizing diagnostics by bringing the power of molecular testing to where it's needed most: in the hands of doctors and patients at the point of care. To accomplish this, we are commercializing a proprietary new CRISPR platform that enables multiplex detection ...
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base ...
Colossal was founded by emerging technology and software entrepreneur Ben Lamm and world-renowned geneticist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for ...
Sherlock Biosciences is developing products that will empower people to access answers and have more control over their health decisions. Through our engineering biology tools, CRISPR-based SHERLOCK™ and synthetic biology-based INSPECTR™, we are bringing together the accuracy of PCR with the ...
At Mammoth, we discover novel CRISPR systems that enable new possibilities for expanding biology. Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential ...
Inscripta is a life science technology company enabling scientists to solve some of today's most pressing challenges with the first benchtop system for genome editing. The company's automated Onyx™ platform, consisting of an instrument, consumables, assays, and software, makes CRISPR-based genome ...
eGenesis is a gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues and cells to address the global organ crisis.
